• Six clinical trials on MSCs approved by US FDA
    Six clinical trials on MSCs approved by US FDA
  • One of the few companies manufacturing both hMSC and hNSC
    One of the few companies manufacturing both hMSC and hNSC
  • First FDA-approved clinical trial using stem cells to treat Alzheimer’s
    First FDA-approved clinical trial using stem cells to treat Alzheimer’s
  • MSCs approved as a treatment of AMI in Kazakhstan
    MSCs approved as a treatment of AMI in Kazakhstan
  • Producing clinical-grade stem cells with strong activity in large scale
    Producing clinical-grade stem cells with strong activity in large scale
  • SCF activity preserved through patented technology for 3 years
    SCF activity preserved through patented technology for 3 years

Add:21st Floor, Block 1, Jusha Center, No.16 Xinyuanli, Chaoyang District, Beijing

Phone: 86-10-64654791

 

 

Copyright ©Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.! 

京ICP备19006400号-1     Powered by 300.cn

About Us



Dr. Alex Kharazi

没有此类产品
Details
 
 
 

Dr. Kharazi finished Medical School in 1978 in Kiev, Ukraine, where he earned his medical degree in internal medicine and pathology. From 1978 to 1981, he was a post- doctoral fellow at the Kiev Institute of Gerontology. Dr. Kharazi was one of the first to discover the inhibitory effects of old thymus in mice and later published over 30 papers on this subject. He is a faculty member at the University of Southern California in Los Angeles, and a named inventor of 8 US patents and various foreign patents.

 
 

Dr. Alex Kharazi

On a
Dr. Nikolai Tankovich
The next article
Dr. Lev Verkh